A CoE that ships, not a CoE that governs into paralysis.
Charter, operating model, staffing, funding, intake, delivery, governance — and a demand pipeline that keeps it in business.
An AI Centre of Excellence concentrates the scarce capability — risk assessment, evaluation design, governance and vendor assessment — so individual teams do not each solve it badly. In a regulated business its most valuable output is usually not models but the intake process and the registry that answers how many AI systems are in use and which touch a regulated record.
Outcomes you can expect
- AI CoE stood up
- Delivery cadence
- Demand pipeline
AI Centre of Excellence (AI CoE) is delivered by our ai transformation practice. Where it saves time, the team uses our products: GxP Copilot for validation lifecycle work and TraceDraft for clinical documentation.
Explore related capabilities: AI Strategy, AI Governance, AI Validation, GenAI Adoption.
Why AI Centres of Excellence Fail in Life Sciences
AI Centres of Excellence are a common organisational response to the challenge of scaling AI adoption across a large life sciences business. They are also a common organisational failure mode: the CoE is established, staffed, and chartered, and then spends its first year debating governance frameworks, evaluating vendors, and reviewing PoC proposals without shipping a single production AI system. The organisation's business units, who needed AI help today, route around the CoE. The CoE becomes a governance bottleneck rather than an enablement function.
The failure pattern is consistent: the CoE is designed around governance rather than delivery. It owns the framework but not the pipeline. It sets standards but does not execute. And it is funded as an overhead function rather than against a delivery portfolio with defined business value targets. A CoE that cannot point to AI systems it has shipped to production within its first six months of operation will lose business unit support and executive patience before it has had the opportunity to demonstrate value.
Designing an AI CoE for Delivery Velocity in Regulated Environments
An AI CoE in a regulated life sciences organisation needs to balance two competing requirements: governance (ensuring that AI systems deployed across the organisation meet regulatory and quality standards) and delivery (actually shipping AI systems that create business value fast enough to justify the investment). The design choice that determines which requirement wins is where the CoE sits in the delivery lifecycle.
A governance-first CoE reviews, approves, and monitors AI systems developed elsewhere in the organisation. A delivery-first CoE builds AI systems itself, applying governance as a quality layer in its own delivery process rather than as an external review gate. In regulated environments, the delivery-first model is superior: the CoE team that builds the system understands its regulatory implications from the design phase, builds validation and governance requirements into the implementation from the start, and owns both the delivery timeline and the compliance outcome.
See it on your own system.
Bring a URS or a system. We show you the validation package it produces.
- We reply within one business day
- We run your URS live on the call
- You get a clear plan and scope